DENYES NANCY (General Counsel) sold 10.5% of their position (322.00 shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $1.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/28/2020ACC: 0001209191-20-032794
Officer· General Counsel
Since Feb 2019
+29.68K
Net shares
Net buyer
$1.2K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
30.89K acquired · 1.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+892.00
Price / share
—
Trade value
—
% of position
41.2%
5/16/2020
2.17K→3.06K
Common Stock
Direct
Shares
−322.00
Price / share
$3.62
Trade value
$1.17K
% of position
10.5%
5/20/2020
3.06K→2.73K
Total
Net shares
+570.00
Net value
-$1.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2020 | M · Option Exercise | +892.00 | — | — | 41.2% | 2.17K | 3.06K |
| Common Stock Direct | 5/20/2020 | S · Sale | −322.00 | $3.62 | $1.17K | 10.5% | 3.06K | 2.73K |
| Total | +570.00 | -$1.17K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
892.00 shares
Shares
−892.00
Strike price
Held after
0.00
Exercisable
—
5/16/2020
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
4.06
Held after
30K
Exercisable
—
5/26/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock892.00 shares | 5/16/2020 | M · Option Exercise | −892.00 | — | 0.00 | |
| Employee Stock Option (right to buy) Direct | Common Stock30K shares | 5/26/2020 | A · Award | +30K | 4.06 | — | 30K |